(DXPE) DXP Enterprises - Overview
Stock: Pumps, Bearings, Power-Transmission, Safety-Products, MRO
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.3% |
| Relative Tail Risk | -6.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 23.37 |
| Character TTM | |
|---|---|
| Beta | 1.451 |
| Beta Downside | 1.579 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.99% |
| CAGR/Max DD | 2.04 |
Description: DXPE DXP Enterprises January 15, 2026
DXP Enterprises Inc. (NASDAQ:DXPE) distributes maintenance, repair, and operating (MRO) products, equipment, and services across the U.S., Canada, and select international markets through three operating segments: Service Centers, Supply Chain Services, and Innovative Pumping Solutions.
The Service Centers segment supplies a broad catalog of MRO items-including bearings, power transmission, fluid power, and safety products-to end-users in oil & gas, manufacturing, chemical processing, food & beverage, water/wastewater, and construction. The Supply Chain Services segment adds value through procurement platforms (SmartAgreement, SmartBuy, SmartSource, SmartStore, SmartVend, SmartServ) that centralize ordering, inventory optimization, and vendor management. The Innovative Pumping Solutions segment designs, remanufactures, and brands custom pump packages, targeting niche industrial applications.
Key data points (FY 2023): revenue of $1.15 billion, operating margin of 6.2 %, and a 4.1 % year-over-year increase in pump-related sales driven by rising demand for water-treatment and oil-field equipment. The business is sensitive to industrial production cycles and commodity price volatility, with oil-field MRO spending historically moving in tandem with upstream capex trends (≈ $150 billion U.S. upstream capex forecast for 2024). Recent strategic initiatives include expanding e-catalog adoption (SmartStore) and leveraging data analytics to improve inventory turns, which have risen to an industry-average 7.4 × in 2023.
For a deeper quantitative dive and peer-adjusted valuation metrics, you may find ValueRay’s analyst toolkit useful as a next step.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 87.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -4.52 > 1.0 |
| NWC/Revenue: 23.71% < 20% (prev 17.81%; Δ 5.90% < -1%) |
| CFO/TA 0.06 > 3% & CFO 88.6m > Net Income 87.2m |
| Net Debt (563.9m) to EBITDA (210.0m): 2.68 < 3 |
| Current Ratio: 2.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.5m) vs 12m ago -0.34% < -2% |
| Gross Margin: 31.52% > 18% (prev 0.31%; Δ 3122 % > 0.5%) |
| Asset Turnover: 146.5% > 50% (prev 141.1%; Δ 5.34% > 0%) |
| Interest Coverage Ratio: 2.80 > 6 (EBITDA TTM 210.0m / Interest Expense TTM 61.6m) |
Altman Z'' 4.47
| A: 0.32 (Total Current Assets 726.9m - Total Current Liabilities 262.3m) / Total Assets 1.44b |
| B: 0.32 (Retained Earnings 455.4m / Total Assets 1.44b) |
| C: 0.13 (EBIT TTM 172.5m / Avg Total Assets 1.34b) |
| D: 0.44 (Book Value of Equity 424.0m / Total Liabilities 956.1m) |
| Altman-Z'' Score: 4.47 = AA |
Beneish M -3.06
| DSRI: 1.00 (Receivables 437.0m/387.4m, Revenue 1.96b/1.74b) |
| GMI: 0.97 (GM 31.52% / 30.53%) |
| AQI: 0.85 (AQ_t 0.38 / AQ_t-1 0.45) |
| SGI: 1.13 (Revenue 1.96b / 1.74b) |
| TATA: -0.00 (NI 87.2m - CFO 88.6m) / TA 1.44b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of DXPE shares?
Over the past week, the price has changed by +7.67%, over one month by +33.56%, over three months by +14.65% and over the past year by +35.22%.
Is DXPE a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DXPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 136.5 | -2.4% |
| Analysts Target Price | 136.5 | -2.4% |
| ValueRay Target Price | 208 | 48.7% |
DXPE Fundamental Data Overview February 03, 2026
P/S = 1.0414
P/B = 4.1719
P/EG = 2.1
Revenue TTM = 1.96b USD
EBIT TTM = 172.5m USD
EBITDA TTM = 210.0m USD
Long Term Debt = 619.4m USD (from longTermDebt, last quarter)
Short Term Debt = 23.8m USD (from shortTermDebt, last quarter)
Debt = 687.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 563.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.60b USD (2.04b + Debt 687.7m - CCE 123.8m)
Interest Coverage Ratio = 2.80 (Ebit TTM 172.5m / Interest Expense TTM 61.6m)
EV/FCF = 61.65x (Enterprise Value 2.60b / FCF TTM 42.3m)
FCF Yield = 1.62% (FCF TTM 42.3m / Enterprise Value 2.60b)
FCF Margin = 2.16% (FCF TTM 42.3m / Revenue TTM 1.96b)
Net Margin = 4.45% (Net Income TTM 87.2m / Revenue TTM 1.96b)
Gross Margin = 31.52% ((Revenue TTM 1.96b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = 31.39% (prev 31.65%)
Tobins Q-Ratio = 1.80 (Enterprise Value 2.60b / Total Assets 1.44b)
Interest Expense / Debt = 2.17% (Interest Expense 14.9m / Debt 687.7m)
Taxrate = 26.56% (7.82m / 29.5m)
NOPAT = 126.7m (EBIT 172.5m * (1 - 26.56%))
Current Ratio = 2.77 (Total Current Assets 726.9m / Total Current Liabilities 262.3m)
Debt / Equity = 1.41 (Debt 687.7m / totalStockholderEquity, last quarter 488.3m)
Debt / EBITDA = 2.68 (Net Debt 563.9m / EBITDA 210.0m)
Debt / FCF = 13.34 (Net Debt 563.9m / FCF TTM 42.3m)
Total Stockholder Equity = 456.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.52% (Net Income 87.2m / Total Assets 1.44b)
RoE = 19.12% (Net Income TTM 87.2m / Total Stockholder Equity 456.0m)
RoCE = 16.04% (EBIT 172.5m / Capital Employed (Equity 456.0m + L.T.Debt 619.4m))
RoIC = 11.70% (NOPAT 126.7m / Invested Capital 1.08b)
WACC = 8.82% (E(2.04b)/V(2.73b) * Re(11.26%) + D(687.7m)/V(2.73b) * Rd(2.17%) * (1-Tc(0.27)))
Discount Rate = 11.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.43%
[DCF Debug] Terminal Value 66.57% ; FCFF base≈62.0m ; Y1≈40.7m ; Y5≈18.6m
Fair Price DCF = N/A (negative equity: EV 317.7m - Net Debt 563.9m = -246.2m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 28.48 | EPS CAGR: -42.40% | SUE: -3.63 | # QB: 0
Revenue Correlation: 91.55 | Revenue CAGR: 16.14% | SUE: 1.02 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.54 | Chg30d=+0.085 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=6.76 | Chg30d=+0.445 | Revisions Net=-1 | Growth EPS=+26.9% | Growth Revenue=+5.6%